Recurrent natalizumab-related aseptic meningitis in a patient with multiple sclerosis

Journal Article

Natalizumab is a recombinant humanized monoclonal antibody that decreases T-cell migration into the central nervous system (CNS) through α4 integrin:adhesion-molecule inhibition, thereby increasing the risk for opportunistic CNS infection. Herein, we report a case of infusion-associated aseptic meningitis in a patient receiving natalizumab.

Full Text

Duke Authors

Cited Authors

  • Foley, RW; Tagg, NT; Schindler, MK; Fenton, KM; Reich, DS; Cortese, I; Mowry, EM

Published Date

  • September 2017

Published In

Volume / Issue

  • 23 / 10

Start / End Page

  • 1424 - 1427

Published By

Electronic International Standard Serial Number (EISSN)

  • 1477-0970

International Standard Serial Number (ISSN)

  • 1352-4585

Digital Object Identifier (DOI)

  • 10.1177/1352458517702533


  • en